| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |